A new drug called Ellorarxine is offering hope to those suffering from motor neurone disease (MND), according to a recent study published in the International Journal of Molecular Sciences.

Renata PLC, a leading pharmaceutical manufacturer in Bangladesh, has become the first company to launch a generic version of Cabergoline 0.5 mg in Australia. The medicine is an effective treatment for ...